A Biodegradable 2D Metallic MoS<sub>2</sub> Genesheet for Synergistic NIR‐II Photothermal Immunotherapy
Developing promising biodegradable second near-infrared (NIR-II) immune agonists to overcome the insufficient immunogenicity of tumor cells and the poor immune response remains challenging. In this work, a biodegradable "2D genesheet" is explored for synergistic NIR-II photothermal immunotherapy. The 2D genesheet is large-scale prepared through flexible supramolecular self-assembly between metallic-MoS<sub>2</sub> and siRNA. The 2D genesheet not only exhibits an excellent photothermal conversion efficiency up to 56% in the NIR-II window, but also features unique H<sub>2</sub>O<sub>2</sub>-responsive biodegradability and high biocompatibility. The 2D genesheet can efficiently deliver siRNA(siIDO) to tumor cells and downregulate indoleamine 2,3-dioxygenase 1 (IDO1) protein expression, exerting intrinsic immune activation and reversing IDO1-mediated immunosuppression. The spatiotemporal-controlled NIR-II phototherapy can elicit systemic immunity by evoking immunogenic cell death, promoting dendritic cell maturation, and increasing T cell infiltration. The bioactive material is able to efficiently inhibit primary and distant tumors, achieving a 100% tumor eradication rate. This study broadens the application prospects of biodegradable NIR-II immune agonists, overcoming the limitations of current immunotherapeutic modalities.
Authors
- Junjie Ren (ORCID: https://orcid.org/0000-0001-6264-5021)
- Changjie Yang
- Alberto Bianco (ORCID: https://orcid.org/0000-0002-1090-296X)
- Mei Yang (ORCID: https://orcid.org/0000-0002-6200-5865)
- Ding‐Kun Ji (ORCID: https://orcid.org/0000-0002-4642-7005)
- Lijuan Zhu (ORCID: https://orcid.org/0000-0002-1409-7443)
- Jie Xu (ORCID: https://orcid.org/0000-0003-1014-3745)
- Xiaobo Gao
Institutions
- Centre National de la Recherche Scientifique (FR)
- Shanghai Jiao Tong University (CN)
- Renji Hospital (CN)
- Université de Strasbourg (FR)
Publication Details
- Journal
- Small
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1002/smll.202502577
- Citations
- 7
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 4.72
Funders
- Natural Science Foundation of Shanghai
- Agence Nationale de la Recherche
- National Natural Science Foundation of China
- Centre National de la Recherche Scientifique
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities